Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Diane Augu-Denechere"'
Autor:
Alicja Puszkiel, Benoit You, Léa Payen, Jonathan Lopez, Jérôme Guitton, Pascal Rousset, Juliette Fontaine, Julien Péron, Denis Maillet, Sophie Tartas, Nathalie Bonnin, Veronique Trillet-Lenoir, Olivier Colomban, Diane Augu-Denechere, Gilles Freyer, Michel Tod
Publikováno v:
Cancer Chemotherapy and Pharmacology. 91:413-425
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::754379a6b9991ef6234b8fcfa1853671
https://doi.org/10.1007/s00280-023-04520-z
https://doi.org/10.1007/s00280-023-04520-z
Autor:
Romain Varnier, Alicja Puszkiel, Michel Tod, Sara Calattini, Lea Payen, Jonathan Lopez, Jérome Guitton, Vérane Schwiertz, Juliette Fontaine, Julien Peron, Denis Maillet, Sophie Tartas, Nathalie Bonnin, Olivier Colomban, Diane Augu-Denechere, Gilles Freyer, Benoit You
Publikováno v:
Cancer Chemotherapy and Pharmacology. 91:361-373
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34c3c8185da30f8bb4b569e8fb983b07
https://doi.org/10.1007/s00280-023-04508-9
https://doi.org/10.1007/s00280-023-04508-9
Autor:
Michel Tod, Diane Augu-Denechere, Sophie Tartas, Jonathan Lopez, Juliette Fontaine, Gilles Freyer, Denis Maillet, Benoit You, Véronique Trillet-Lenoir, Nathalie Bonnin, Alicja Puszkiel, Jérôme Guitton, Olivier Colomban, Léa Payen, P. Rousset, Julien Péron
Publikováno v:
Cancer Research. 80:CT148-CT148
Objectives: Defining the optimal doses & dosing schedules of combined targeted drugs is a challenge. Blocking both the PI3K-AKT-mTor and RAS-RAF-ERK pathways is a rationale therapeutic strategy in solid tumors. However, the phase 1 trials of everolim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0964951a7d490497fc41f7467e9c6183
https://doi.org/10.1158/1538-7445.am2020-ct148
https://doi.org/10.1158/1538-7445.am2020-ct148